TNFRSF25
Tumor necrosis factor receptor superfamily member 25
Also known as: APO-3, DDR3, DR3, LARD, TNFRSF12, TNR25_HUMAN, TR3, TRAMP, WSL-1, WSL-LR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q93038
- Gene
- TNFRSF25
- Ensembl
- ENSG00000215788
- Chromosome
- 1
- Canonical length
- 417 aa
- Protein class
- Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites
- Secretome location
- Secreted - unknown location
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed preferentially in the tissues enriched in lymphocytes, and it may play a role in regulating lymphocyte homeostasis. This receptor has been shown to stimulate NF-kappa B activity and regulate cell apoptosis. The signal transduction of this receptor is mediated by various death domain containing adaptor proteins. Knockout studies in mice suggested the role of this gene in the removal of self-reactive T cells in the thymus. Multiple alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported, most of which are potentially secreted molecules. The alternative splicing of this gene in B and T cells encounters a programmed change upon T-cell activation, which predominantly produces full-length, membrane bound isoforms, and is thought to be involved in controlling lymphocyte proliferation induced by T-cell activation. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
417 residues, UniProt reviewed canonical sequence.
>Q93038|TNFRSF25
1 MEQRPRGCAA VAAALLLVLL GARAQGGTRS PRCDCAGDFH KKIGLFCCRG CPAGHYLKAP
61 CTEPCGNSTC LVCPQDTFLA WENHHNSECA RCQACDEQAS QVALENCSAV ADTRCGCKPG
121 WFVECQVSQC VSSSPFYCQP CLDCGALHRH TRLLCSRRDT DCGTCLPGFY EHGDGCVSCP
181 TSTLGSCPER CAAVCGWRQM FWVQVLLAGL VVPLLLGATL TYTYRHCWPH KPLVTADEAG
241 MEALTPPPAT HLSPLDSAHT LLAPPDSSEK ICTVQLVGNS WTPGYPETQE ALCPQVTWSW
301 DQLPSRALGP AAAPTLSPES PAGSPAMMLQ PGPQLYDVMD AVPARRWKEF VRTLGLREAE
361 IEAVEVEIGR FRDQQYEMLK RWRQQQPAGL GAVYAALERM GLDGCVEDLR SRLQRGPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TNFRSF25 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 42 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 42 nTPM
- spleen: 40 nTPM
- pituitary gland: 27 nTPM
- skin: 24 nTPM
- esophagus: 9 nTPM
- heart muscle: 8 nTPM
Single-cell type
- innate lymphoid cells: 132 nCPM
- corticotrophs: 74 nCPM
- brain excitatory neurons: 59 nCPM
- adipocytes: 37 nCPM
- thyrotrophs: 35 nCPM
- adrenal medulla cells: 32 nCPM
Immune cell
- T-reg: 7.9 nTPM
- MAIT T-cell: 5.6 nTPM
- memory CD4 T-cell: 4.4 nTPM
- naive CD4 T-cell: 4.4 nTPM
- memory CD8 T-cell: 2.2 nTPM
- gdT-cell: 1 nTPM
Brain region
- cerebellum: 19 nTPM
- cerebral cortex: 6.8 nTPM
- choroid plexus: 6.5 nTPM
- hippocampal formation: 6.3 nTPM
- hypothalamus: 5.8 nTPM
- pons: 5.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.6
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.57
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- apoptotic signaling pathway
- cell surface receptor signaling pathway
- regulation of apoptotic process
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Death domain
- TNFR/NGFR cysteine-rich region
- Death-like domain superfamily
- TNFR/NGFR cysteine-rich region
- Death domain
- Tumour necrosis factor receptor 25
- Tumor necrosis factor receptor 25, N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TNFRSF25 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TNFRSF25 as an antibody target. Whether an autoantibody or antibody against TNFRSF25 could matter depends on whether native TNFRSF25 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TNFRSF25 is annotated at the cell surface, where native TNFRSF25 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TNFRSF25 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...